The induction of CD11b 
INTRODUCTION
Tumors employ a wide array of immunosuppressive strategies by which they blunt immune responses and limit the effect of immunotherapy 1 . In this regard, tumors are found to affect myelopoiesis and induce the expansion of myeloid cells with immunosuppressive activity, in both animal models and human patients [2] [3] [4] [5] [6] [7] [8] [9] [10] . These cells are referred to as myeloid-derived suppressor cells (MDSCs), which are in mice typically identified by the coexpression of the CD11b and Gr-1 surface markers 11 .
Tumor-induced CD11b + Gr-1 + cells accumulate in the bone marrow, spleen and blood, and are considered to be a heterogeneous population consisting of different myeloid cell types in various maturation states. Despite of this notion, these cells are typically studied as a bulk population and only a few reports have addressed a further refinement of this population 3, 8, 12 .
It has been suggested that different tumor-derived factors, such as granulocyte macrophage-colony stimulating factor (GM-CSF), vascular endothelial growth factor (VEGF), IL-1β and prostaglandins can mobilize MDSC recruitment from bone marrow hematopoietic precursors and induce the immunosuppressive phenotype [13] [14] [15] [16] [17] [18] .
While this immunosuppressive phenotype is a trademark of MDSCs, there is no clear consensus on their suppressive mechanism. Nevertheless, the L-arginine metabolism often seems to play a central role in the immune suppressive activity of MDSCs. Larginine can be metabolized by inducible nitric oxide synthase (iNOS or Nos2), generating citrulline and nitric oxide (NO), or can be converted into urea and Lornithine by arginase 19 . MDSCs expressing arginase-1 reduce the availability of Larginine, which can result in the loss of CD3ζ expression and impaired T-cell function 7 . Others have shown that production of NO by iNOS-expressing MDSCs, is sufficient for blocking T-cell responses 8 . Furthermore, it has been suggested that the simultaneous expression of both enzymes can result in superoxide production, ultimately giving rise to T-cell suppressive reactive nitrogen-oxide species (RNOS) such as peroxynitrite 20 . Other studies have shown that MDSCs can produce high amounts of the T-cell suppressive reactive oxygen species (ROS) H 2 O 2 after antigenspecific interaction with CD8 + T cells 5 . Whether these different suppressor functions of MDSCs can be attributed to distinct MDSC subpopulations is unknown.
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In this study, we defined the phenotype of discrete MDSC subfractions from two genetically unrelated T-cell lymphoma models and assessed their suppressive potency and mechanism towards antigen-driven or polyclonal T-cell stimulation, employing different in vitro stimulation protocols. Interestingly, though both mononuclear and polymorphonuclear MDSC suppress antigen-specific T-cell responses through an at least partially IFN-γ-regulated mechanism, they employ distinct signaling pathways and effector molecules. Moreover, we show that suppression of polyclonal T-cell responses depends on the ability of the mononuclear MDSC fraction to efficiently differentiate towards suppressive macrophages. Of importance, the latter capacity is differentially regulated by different tumors.
MATERIALS AND METHODS

Mice, cell lines and tumor growth
6-to 9-weeks old female AKR (H-2 k ) and C57BL/6 (H-2 b ) mice were purchased from
Harlan (Horst, The Netherlands) and (AKR x C57BL/6)F1 mice were bred in our animal facilities. OT-1 and OT-2 mice were a gift of Dr. Muriel Moser (ULB, Brussels, Belgium). C57BL/6 β2-microglobulin -/-, STAT1 -/-and iNOS -/-mice were provided by Dr. Georges Leclercq (UZGent, Ghent, Belgium), Dr. Chantal Mathieu (KUL, Leuven, Belgium) and Dr. Anje Cauwels (UGent, Ghent, Belgium), respectively.
The BW-Sp3 cell line was obtained from the original BW5147 T-cell lymphoma, and EG7 is a chicken ovalbumin-transfected EL-4 thymoma, as described earlier 21, 22 .
Cancer cells were maintained in RPMI1640 medium, supplemented with 10% heatinactivated FCS, 0.03% L-glutamine, 100 mg/ml streptomycin and 100 mg/ml penicillin (Invitrogen). For splenocyte cultures, this medium was further supplemented with 1mM non-essential amino acids, 1mM sodium pyruvate (Invitrogen) and 0.02 mM 2-ME.
Mice were injected subcutaneously in the flank with 3x10 6 BW-Sp3 or EG7 cells and were used when average tumor diameters reached 15-20 mm. Fractalkine-Fc and anti-humanFc/Cy5, to assess the expression of CX 3 CR1, were provided by Dr. Steffen Jung (Weizmann Institute of Science, Rehovot, Israel). Nonlabeled anti-SIGN-R1 (ER-TR9) and anti-MGL1/2 (ER-MP23) were provided by Dr.
FACS staining and flow cytometry
Pieter Leenen, (Erasmus MC, Rotterdam, The Netherlands). Intracellular Foxp3 staining was performed following the manufacturer's instructions (eBioscience). Tumor dissociation was performed as described earlier 12 .
FACS data were acquired using a FACSVantage SE flow cytometer or FACS Canto 2 (BD Biosciences).
Isolation of MDSCs and MDSC subfractions
To purify tumor-induced CD11b anti-CD19 and anti-CD11c microbeads and LD columns following the manufacturer's instructions (Miltenyi Biotec). In the remaining population, CD11b + cells were positively selected via anti-CD11b microbeads using LS columns (Miltenyi Biotec), providing purified total MDSCs. To purify Ly6G + MDSCs, CD19/CD11c-depleted splenocytes from tumor-bearing mice were stained with biotin-coupled anti-Ly6G, followed by positive magnetic selection using anti-biotin microbeads, following the manufacturer's instructions (anti-Ly6G microbead kit, Miltenyi Biotec). To further purify Ly6G -MDSCs from the same spleen, remaining cells were passed over an LD depletion column to make sure all Ly6G + cells were eliminated, followed by a positive selection using anti-CD11b microbeads. The purity of the total MDSC population or the MDSC subfractions was typically higher than 90 %.
Morphological analysis
Cytospins were obtained by spinning down cells on pre-coated microscope slides (Thermo Shandon), fixing with methanol and staining with May-Grünwald and Giemsa dye for 5 and 15 minutes, respectively. was added and cells were allowed to proliferate for another 18h before incorporated radioactivity was measured (= short-term culture protocol, 24+18 = 42h total). Anti-IFN-γ (10 µg/ml, clone F3, provided by Dr. Hubertine Heremans, Rega Institute, Leuven, Belgium), L-NMMA (0.5 mM, Sigma), nor-NOHA (0.5 mM, Calbiochem), SC-791 (100 nM, Calbiochem), catalase (1000 U/ml, Sigma) and superoxide dismutase (SOD, 200 U/ml, Sigma) were added from the beginning of the culture. % suppression of proliferation without inhibitor is calculated as:
Suppression of antigen-specific T-cell proliferation
% suppression of proliferation with inhibitor is calculated as:
Relative % suppression is calculated as: %Suppression _ with _ inhibitor %Suppression _ without _ inhibitor ×100.
Suppression of polyclonal T-cell proliferation
Purified MDSCs were added in varying amounts to 2x10 5 naive AKR, C57BL/6 or (AKR x C57BL/6)F1 splenocytes, in flat-bottom 96-well plates. These cocultures were promptly stimulated with 1 µg/ml anti-CD3 (or alternatively 2.5 µg/ml Concanavalin A), 24h later 3 H-thymidine was added and cells were allowed to proliferate for another 18h before measurement (= short-term culture protocol).
Alternatively, MDSCs and splenocytes were cocultured for 48h, at which time point anti-CD3 was added. Again, 3 H-thymidine was added 24h later and cells were allowed to proliferate for another 18h before measurement (= long-term culture protocol). Anti-IFN-γ, L-NMMA and nor-NOHA were added simultaneously with anti-CD3.
Quantification of NO 2 -
Nitrite quantification was assayed by a standard Greiss reaction, as described previously 9 .
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RESULTS
CD11b
As previously reported 6, 9 , subcutaneous inoculation of these cancer cells resulted in a profound expansion of splenic CD11b To further investigate the characteristics of these MDSC subfractions, they were purified to near uniformity. While purified Ly6G + MDSCs displayed a high SSC profile ( Figure 1Bii ) in accordance with their polymorphonuclear morphology ( Figure   1C ; these cells will be termed PMN-MDSC), Ly6G -MDSCs were mononuclear ( Figure 1C ; these cells will be termed MO-MDSC) and had on average a lower SSC (Figure 1Biii) . Moreover, the observed heterogeneity in Gr-1 expression of (Figures 1Bii, 1Biii ).
To gain further insight in the maturation state, lineage commitment and potential functions of these MDSC subpopulations, their surface marker expression was extensively studied ( Together, these results show that MDSCs can be clearly subdivided into two distinct populations. Furthermore, these subfractions were observed in independent tumor models, with an almost identical phenotype, suggesting that this is a general feature of tumor-induced MDSCs.
The phenotype and cellular composition of MO-MDSCs changes during the course of tumor growth, while that of PMN-MDSCs remains static
To determine the kinetics of MO-and PMN-MDSC induction, the percentage of these cells as compared to the total splenocyte population was measured at various time points after tumor injection. This showed that MO-and PMN-MDSCs were induced with similar kinetics (Figure 2A ). Table 2 (data not shown). Naive and tumor-induced monocytes (Gate R2) also showed a similar expression for the majority of these markers (data not shown). Interestingly however, in both tumor models, three markers were consistently found to be differentially expressed between naive and tumor-induced splenic monocytes ( Figure 2C ). These included the transferrin receptor CD71 -which was only detected on tumor-induced monocytes-and CD80 and CD115, which reached a higher expression on tumor-induced as compared to naive monocytes. As described earlier, Sca-1 was uniquely expressed on BW-Sp3-induced monocytes, and appeared to be absent from naive monocytes. Together these findings suggest that tumorinduced splenic MO-MDSCs are monocytes with a potentially unique activation and/or maturation status.
Finally, based on recent findings demonstrating a potential induction of Foxp3 Well known IFN-γ-regulated genes with a potentially negative impact on T-cell activation include iNOS (NO production), COX-2 (prostaglandin production) and gp91phox (subunit of the ROS-producing NADPH oxidase) [31] [32] [33] . In addition, iNOS, in concert with arginase-1, has been reported as a major contributor to the production of T-cell suppressive RNOS by MDSCs 20 . In an attempt to unravel the suppressive mechanism of the MDSC subfractions, specific inhibitors of each pathway were employed in OVA-stimulated cultures (
Figure 5B can be switched on in an in vivo environment such as the tumor. 36 In addition, such MDSC-derived mature myeloid cells might possess a very potent anti-proliferative capacity 12 . Neither BW-Sp3 nor EG7 freshly purified total MDSCs were able to suppress anti-CD3-induced proliferation of AKR or C57BL/6 T-cells in short-term cultures ( Figure 6A ). However, when BW-Sp3 MDSCs and naive splenocytes were first coincubated for two days, prior to adding anti-CD3 (long-term culture), a profound dose-dependent suppression of T-cell proliferation was observed, which was These results show that MO-MDSCs might possess suppressive activity at two levels, either as immature cells or as differentiated macrophages.
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The differences in MDSC differentiation observed between EG7 and BW-Sp3 are tumor-driven
Finally, we wondered whether the differences between EG7 and BW-Sp3 MOMDSCs were a tumor-driven phenomenon, or whether these were intrinsic differences between C57BL/6 and AKR monocytes, irrespective of the tumors. To discriminate between these possibilities, EG7 and BW-Sp3 tumors were grown in (AKR x C57BL/6)F1 mice. Both EG7 and BW-Sp3 F1 PMN-and MO-MDSCs had a similar surface marker profile as their C57BL/6 or AKR counterparts (data not shown), andin line with previous results-dose-dependently suppressed OT-1 T-cell responses in a short-term assay ( Figure 7A) ; the MO-MDSC fraction through a partly NO-mediated mechanism ( Figure 7B ). Next, F1 MDSCs were assessed for their suppressive activity towards anti-CD3-stimulated F1 splenocytes in a long-term assay. Interestingly, while
EG7 F1 MDSCs mice did not influence polyclonal T-cell activation, F1 BW-Sp3
MDSCs were again suppressive ( Figure 7C ). As anticipated, only BW-Sp3 induced F1 MO-MDSCs were able to recapitulate this suppression ( Figure 7D Both MO-and PMN-MDSCs were shown to efficiently suppress antigen-driven CD8 + T-cell proliferation in short-term culture assays. While T-cell suppression by granulocytic cells has been reported in human cancer patients 7, 38 , this is the first study
showing that PMN cells, with a potential T-cell suppressive activity, are expanded in tumor-bearing mice. In this context, a recent report indicated that G-CSF treatment can induce low-density granulocytes, which inhibit acute graft-versus-host disease in mice 42 .
We wondered whether the suppression mediated by tumor-induced MDSCs relied on the induction of T-cell anergy through an MHC-restricted presentation of antigen, as described by others 4, 6 . By assessing the suppressive activity of MHC I-deficient or allogeneic MDSCs, this was shown to be unlikely in our in vitro cultures. However, we do not exclude that antigen-specific induction of T-cell anergy might be an To obtain MDSCs from an identical genetic background, we injected BW-Sp3 and EG7 in (AKR x C57BL/6)F1 mice. In this given background, we found that the functional differences in EG7 and BW-Sp3 MDSCs were tumor-driven. However, these data do not exclude the possibility that EG7 and BW-Sp3 instruct different characteristics onto MDSCs in mice with a somewhat altered genetic program and a 
MO-MDSC PMN-MDSC
EG7 Sp3 EG7 Sp3
Myeloid maturation markers individually purified from BW-Sp3 tumor-bearing F1 mice and were added in varying amounts to naive F1 splenocytes, which were subjected to the "long-term culture"
protocol.
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